Sfoglia per Autore
p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and oncophenotype reversion in rhabdomyosarcoma cells
2005 Ciccarelli, Carmela; Marampon, Francesco; Scoglio, Arianna; Mauro, Annunziata; Giacinti, Cristina; De Cesaris, Paola; Zani, Bianca M.
HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers
2006 Vulcano, Francesca; Ciccarelli, Carmela; Mattia, Gianfranco; Marampon, Francesco; Giampiero, Macioce; Milazzo, Luisa; Pascuccio, Massimiliano; Zani, Bianca M; Giampaolo, Adele; Hassan, Hamisa J
Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors
2006 Marampon, Franceso; Ciccarelli, Carmela; Zani, Bianca M.
ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program
2007 Pelosi, M.; Marampon, F.; Perlas, E.; Caputo, Viviana; Cianetti, L.; Berno, V.; Narumiya, S.; Kang, S. W.; Musaro', Antonio; Rosenthal, N.; Zani, Bianca M.; Prudente, Sabrina
Nerve growth factor regulation of cyclin D1 in PC12 cells through a p21 RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-κB
2008 Marampon, Francesco; Casimiro, Mathew C.; Fu, Maofu; Powell, Michael J.; Popov, Vladimir M.; Lindsay, Jaime; Zani, Bianca M.; Ciccarelli, Carmela; Watanabe, Genichi; Lee, Richard J.; Pestell, Richard G.
Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy
2008 Bossi, Gianluca; Marampon, Francesco; Maor-Aloni, Revital; Zani, Bianca; Rotter, Varda; Oren, Moshe; Strano, Sabrina; Blandino, Giovanni; Sacchi, Ada
MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma
2009 Marampon, Francesco; Bossi, Gianluca; Ciccarelli, Carmela; Di Rocco, Agnese; Sacchi, Ada; Pestell, Richard G.; Zani, Bianca M.
The TORC1/TORC2 inhibitor, palomid 529 (P529), reduces tumor growth and sensitizes to chemotherapy and radiotherapy aggressive hormone refractory prostate cancer cells both in vitro and in vivo
2010 Festuccia, C.; Gravina, GIOVANNI LUCA; Marampon, F.; Biordi, L.; Sherris, D.; Tombolini, Vincenzo
Histone deacetylase inhibitor Belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth hormone refractory models
2010 Festuccia, C.; Gravina, G. L.; Marampon, F.; Biordi, L. A.; Ricevuto, E.; Ficorella, C.; Tombolini, Vincenzo
MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by down regulating growth and DNA repair signals
2010 Marampon, F.; Gravina, G. L.; Bonfili, P.; Di Staso, M.; Polidoro, L.; Festuccia, C.; Pestell, R. G.; Zani, B. M.; Tombolini, Vincenzo
Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation
2010 Gravina, GIOVANNI LUCA; Claudio, Festuccia; Marampon, Francesco; Popov, Vladimir M.; Pestell, Richard G.; Zani, Bianca M.; Tombolini, Vincenzo
The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer
2010 Di Nicola, L.; Gravina, G. L.; Marampon, F.; Bonfili, P.; Buonopane, S.; Di Staso, M.; Festuccia, C.; Franzese, P.; Tombolini, Mario; Tombolini, Vincenzo
AZACITIDINE TREATMENT SENSITIZES AGAINST BICALUTAMIDE AND RADIOTHERAPY IN ANDROGEN INDEPENDENT PROSTATE CANCER CELLS
2010 Gravina, GIOVANNI LUCA; Festuccia, C; Di Sante, S; Marampon, F; Fratticci, A; Carosa, E; Castri, A; Ventura, L; Jannini, Ea; Tombolini, Vincenzo
5-azacitidine restores and amplifies the response to bicalutamide and radiotherapy on preclinical models of androgen receptor expressing or deficient prostate tumors
2010 Luca, Gg; Festuccia, C.; Marampon, F.; Bonfili, P.; Di Staso, M.; Di Sante, S.; Pestell, R. G.; Tombolini, Vincenzo
MEK/ERK Inhibition by U0126 Radiosensitizes Rhabdomyosarcoma Cells In Vitro and In Vivo
2010 Marampon, F.; Gravina, G. L.; Bonfili, P.; Di Staso, M.; Fardella, C.; Polidoro, L.; Festuccia, C.; Pestell, R. G.; Tombolini, Vincenzo; Zani, B. M.
A Feasibility Study of Percutaneous Radiofrequency Ablation with Radiotherapy in Painful Osteolytic Bone Metastases
2010 Gravina, G.; Di Staso, M.; Zugaro, L.; Marampon, F.; Bonfili, P.; Fardella, C.; Buonopane, S.; Franzese, P.; Masciocchi, C.; Tombolini, Vincenzo
5-Azacitidine Restores and Amplifies the Bicalutamide Response on Preclinical Models of Androgen Receptor Expressing or Deficient Prostate Tumors
2010 Gravina, GIOVANNI LUCA; Marampon, Francesco; Mario Di Staso, ; Pierluigi, Bonfili; Vitturini, Alessandro; Jannini, Emmanuele A.; Pestell, Richard G.; Tombolini, Vincenzo; Claudio, Festuccia
HISTONE DEACETYLASE INHIBITOR, ROMIDEPSIN (FK228) IMPROVES ANTITUMOR EFFECTS OF DOCETAXEL AND CISPLATIN IN MODELS OF AGGRESSIVE PROSTATE CANCER
2011 Festuccia, C; Gravina, Gl; Marampon, F; Biordi, L; Angelini, M; D'Ascenzo, S; Dolo, V; Tombolini, Vincenzo
The chemokine receptor CXCR7 is highly expressed in bone metastatic lesions of human prostate cancer and mediates tumor cell growth and invasiveness in preclinical models
2011 Ravina, G. L.; Angelini, M.; Montironi, R.; Ventura, L.; Marampon, F.; Pratesi, G.; Tortoreto, M.; Tombolini, Vincenzo; Festuccia, C.
MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals
2011 Marampon, F.; Gravina, G. l.; Di Rocco, A.; Bonfili, P.; Di Staso, M.; Fardella, C.; Polidoro, L.; Ciccarelli, C.; Festuccia, C.; Popov, V. m.; Pestell, R. g.; Tombolini, Vincenzo; Zani, B. m.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and oncophenotype reversion in rhabdomyosarcoma cells | 2005 | Ciccarelli, Carmela; Marampon, Francesco; Scoglio, Arianna; Mauro, Annunziata; Giacinti, Cristina; De Cesaris, Paola; Zani, Bianca M. | |
| HDAC inhibition is associated to valproic acid induction of early megakaryocytic markers | 2006 | Vulcano, Francesca; Ciccarelli, Carmela; Mattia, Gianfranco; Marampon, Francesco; Giampiero, Macioce; Milazzo, Luisa; Pascuccio, Massimiliano; Zani, Bianca M; Giampaolo, Adele; Hassan, Hamisa J | |
| Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors | 2006 | Marampon, Franceso; Ciccarelli, Carmela; Zani, Bianca M. | |
| ROCK2 and its alternatively spliced isoform ROCK2m positively control the maturation of the myogenic program | 2007 | Pelosi, M.; Marampon, F.; Perlas, E.; Caputo, Viviana; Cianetti, L.; Berno, V.; Narumiya, S.; Kang, S. W.; Musaro', Antonio; Rosenthal, N.; Zani, Bianca M.; Prudente, Sabrina | |
| Nerve growth factor regulation of cyclin D1 in PC12 cells through a p21 RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-κB | 2008 | Marampon, Francesco; Casimiro, Mathew C.; Fu, Maofu; Powell, Michael J.; Popov, Vladimir M.; Lindsay, Jaime; Zani, Bianca M.; Ciccarelli, Carmela; Watanabe, Genichi; Lee, Richard J.; Pestell, Richard G. | |
| Conditional RNA interference in vivo to study mutant p53 oncogenic gain of function on tumor malignancy | 2008 | Bossi, Gianluca; Marampon, Francesco; Maor-Aloni, Revital; Zani, Bianca; Rotter, Varda; Oren, Moshe; Strano, Sabrina; Blandino, Giovanni; Sacchi, Ada | |
| MEK/ERK inhibitor U0126 affects in vitro and in vivo growth of embryonal rhabdomyosarcoma | 2009 | Marampon, Francesco; Bossi, Gianluca; Ciccarelli, Carmela; Di Rocco, Agnese; Sacchi, Ada; Pestell, Richard G.; Zani, Bianca M. | |
| The TORC1/TORC2 inhibitor, palomid 529 (P529), reduces tumor growth and sensitizes to chemotherapy and radiotherapy aggressive hormone refractory prostate cancer cells both in vitro and in vivo | 2010 | Festuccia, C.; Gravina, GIOVANNI LUCA; Marampon, F.; Biordi, L.; Sherris, D.; Tombolini, Vincenzo | |
| Histone deacetylase inhibitor Belinostat (PXD-101) represses androgen receptor expression and acts synergistically with castration and bicalutamide treatment to inhibit prostate cancer growth hormone refractory models | 2010 | Festuccia, C.; Gravina, G. L.; Marampon, F.; Biordi, L. A.; Ricevuto, E.; Ficorella, C.; Tombolini, Vincenzo | |
| MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by down regulating growth and DNA repair signals | 2010 | Marampon, F.; Gravina, G. L.; Bonfili, P.; Di Staso, M.; Polidoro, L.; Festuccia, C.; Pestell, R. G.; Zani, B. M.; Tombolini, Vincenzo | |
| Biological rationale for the use of DNA methyltransferase inhibitors as new strategy for modulation of tumor response to chemotherapy and radiation | 2010 | Gravina, GIOVANNI LUCA; Claudio, Festuccia; Marampon, Francesco; Popov, Vladimir M.; Pestell, Richard G.; Zani, Bianca M.; Tombolini, Vincenzo | |
| The impact of conventional or hypofractionated radiotherapy on voice quality and oncological outcome in patients with early glottic cancer | 2010 | Di Nicola, L.; Gravina, G. L.; Marampon, F.; Bonfili, P.; Buonopane, S.; Di Staso, M.; Festuccia, C.; Franzese, P.; Tombolini, Mario; Tombolini, Vincenzo | |
| AZACITIDINE TREATMENT SENSITIZES AGAINST BICALUTAMIDE AND RADIOTHERAPY IN ANDROGEN INDEPENDENT PROSTATE CANCER CELLS | 2010 | Gravina, GIOVANNI LUCA; Festuccia, C; Di Sante, S; Marampon, F; Fratticci, A; Carosa, E; Castri, A; Ventura, L; Jannini, Ea; Tombolini, Vincenzo | |
| 5-azacitidine restores and amplifies the response to bicalutamide and radiotherapy on preclinical models of androgen receptor expressing or deficient prostate tumors | 2010 | Luca, Gg; Festuccia, C.; Marampon, F.; Bonfili, P.; Di Staso, M.; Di Sante, S.; Pestell, R. G.; Tombolini, Vincenzo | |
| MEK/ERK Inhibition by U0126 Radiosensitizes Rhabdomyosarcoma Cells In Vitro and In Vivo | 2010 | Marampon, F.; Gravina, G. L.; Bonfili, P.; Di Staso, M.; Fardella, C.; Polidoro, L.; Festuccia, C.; Pestell, R. G.; Tombolini, Vincenzo; Zani, B. M. | |
| A Feasibility Study of Percutaneous Radiofrequency Ablation with Radiotherapy in Painful Osteolytic Bone Metastases | 2010 | Gravina, G.; Di Staso, M.; Zugaro, L.; Marampon, F.; Bonfili, P.; Fardella, C.; Buonopane, S.; Franzese, P.; Masciocchi, C.; Tombolini, Vincenzo | |
| 5-Azacitidine Restores and Amplifies the Bicalutamide Response on Preclinical Models of Androgen Receptor Expressing or Deficient Prostate Tumors | 2010 | Gravina, GIOVANNI LUCA; Marampon, Francesco; Mario Di Staso, ; Pierluigi, Bonfili; Vitturini, Alessandro; Jannini, Emmanuele A.; Pestell, Richard G.; Tombolini, Vincenzo; Claudio, Festuccia | |
| HISTONE DEACETYLASE INHIBITOR, ROMIDEPSIN (FK228) IMPROVES ANTITUMOR EFFECTS OF DOCETAXEL AND CISPLATIN IN MODELS OF AGGRESSIVE PROSTATE CANCER | 2011 | Festuccia, C; Gravina, Gl; Marampon, F; Biordi, L; Angelini, M; D'Ascenzo, S; Dolo, V; Tombolini, Vincenzo | |
| The chemokine receptor CXCR7 is highly expressed in bone metastatic lesions of human prostate cancer and mediates tumor cell growth and invasiveness in preclinical models | 2011 | Ravina, G. L.; Angelini, M.; Montironi, R.; Ventura, L.; Marampon, F.; Pratesi, G.; Tortoreto, M.; Tombolini, Vincenzo; Festuccia, C. | |
| MEK/ERK Inhibitor U0126 Increases the Radiosensitivity of Rhabdomyosarcoma Cells In vitro and In vivo by Downregulating Growth and DNA Repair Signals | 2011 | Marampon, F.; Gravina, G. l.; Di Rocco, A.; Bonfili, P.; Di Staso, M.; Fardella, C.; Polidoro, L.; Ciccarelli, C.; Festuccia, C.; Popov, V. m.; Pestell, R. g.; Tombolini, Vincenzo; Zani, B. m. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile